Table 1

Expression of the SART-1800 and SART-1259 Proteins in Normal and Cancer Cells and Tissues

SART-1800 (nucleus)*SART-1259 (cytosol)‡
Cell linesTissuesCell linesTissues
Normal
 PBMC0/5§0/5
 PHA blast2/20/2
 Fibroblast2/20/2
 Fetal liver1/11/1
 Newborn liver0/10/1
 Liver0/10/1
 Testis1/13/3
 Placenta0/10/2
 Esophagus0/20/4
 Pancreas0/10/1
Cancer
 Head and neck SCC2/22/23/57/7 (100%)
 Esophageal SCC5/53/54/618/30 (60%)
 Lung cancer
  Adenocarcinoma3/37/73/616/35 (47%)
  SCC2/23/43/3 8/17 (47%)
 Leukemia4/44/40/16 0/10 (0%)
 Melanoma1/1 0/2 0/10 (0%)
  • *  Expression of the SART-1800 protein in the nucleus of various normal and cancer cells and tissues was investigated by Western blot analysis with anti–SART-1800/GST Ab.  

  •  Expression of the SART-1259 protein in the cytosol of various normal and cancer cells and tissues was investigated by Western blot analysis with anti–SART-16A1-1D7/GST Ab.  

  • §  Number of positive per total samples tested are shown.